Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2002)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
359
Price
$321.58
Total Value
$115.45K
Shares Held After
21,860
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
722
Price
$320.51
Total Value
$231.41K
Shares Held After
22,219
% of Holdings
3.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
282
Price
$318.62
Total Value
$89.85K
Shares Held After
22,941
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
289
Price
$316.55
Total Value
$91.48K
Shares Held After
23,223
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
463
Price
$321.50
Total Value
$148.85K
Shares Held After
23,406
% of Holdings
1.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
640
Price
$320.48
Total Value
$205.11K
Shares Held After
23,869
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
317
Price
$319.06
Total Value
$101.14K
Shares Held After
24,509
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
355
Price
$316.74
Total Value
$112.44K
Shares Held After
24,826
% of Holdings
1.4%
ARTIVION, INC. (AORT)
Holloway Jean F — SVP, General Counsel
Shares
3,843
Price
$37.78
Total Value
$145.17K
Shares Held After
194,057
% of Holdings
1.9%
Airsculpt Technologies, Inc. (AIRS)
Chernett Jorey — 10% Owner
Shares
80,000
Price
$1.71
Total Value
$136.80K
Shares Held After
6,322,611
% of Holdings
1.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,519
Price
$69.33
Total Value
$451.98K
Shares Held After
767,780
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
13,481
Price
$68.85
Total Value
$928.17K
Shares Held After
774,299
% of Holdings
1.7%
ARTIVION, INC. (AORT)
Horton Amy — VP, Chief Accounting Officer
Shares
901
Price
$37.78
Total Value
$34.04K
Shares Held After
139,088
% of Holdings
0.6%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Farmer Michele — Chief Accounting Officer
Shares
2,979
Price
$1.51
Total Value
$4.51K
Shares Held After
305,948
% of Holdings
1.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
HENRY CHRISTIAN O — President & CEO
Shares
12,497
Price
$1.51
Total Value
$18.92K
Shares Held After
3,581,813
% of Holdings
0.3%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Van Oene Mark — Chief Operating Officer
Shares
6,504
Price
$1.51
Total Value
$9.85K
Shares Held After
2,243,634
% of Holdings
0.3%
Progyny, Inc. (PGNY)
Swartz Allison — EVP, GC
Shares
4,157
Price
$17.40
Total Value
$72.33K
Shares Held After
89,879
% of Holdings
4.4%
Progyny, Inc. (PGNY)
Swartz Allison — EVP, GC
Shares
500
Price
$17.40
Total Value
$8.70K
Shares Held After
94,036
% of Holdings
0.5%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
10,000
Price
$3.63
Total Value
$36.30K
Shares Held After
382,702
% of Holdings
2.6%
EXAGEN INC. (XGN)
ABALLI JOHN — Director
Shares
15,698
Price
$3.62
Total Value
$56.83K
Shares Held After
687,299
% of Holdings
2.2%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
200
Price
$41.66
Total Value
$8.33K
Shares Held After
97,994
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$40.56
Total Value
$93.29K
Shares Held After
98,194
% of Holdings
2.3%
INTUITIVE SURGICAL INC (ISRG)
Curet Myriam — EVP & Chief Medical Officer
Shares
4,728
Price
$487.18
Total Value
$2.30M
Shares Held After
409
% of Holdings
92.0%
CVRx, Inc. (CVRX)
Adamson Philip B. — Chief Medical Officer
Shares
1,262
Price
$7.90
Total Value
$9.97K
Shares Held After
61,578
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
8,135
Price
$22.80
Total Value
$185.48K
Shares Held After
76,346
% of Holdings
9.6%
CVRx, Inc. (CVRX)
VERRASTRO PAUL — CHIEF MKTG & STRAT OFFICER
Shares
1,284
Price
$7.90
Total Value
$10.15K
Shares Held After
60,551
% of Holdings
2.1%
Ultragenyx Pharmaceutical Inc. (RARE)
Crombez Eric — EVP and Chief Medical Officer
Shares
7,029
Price
$22.80
Total Value
$160.26K
Shares Held After
76,301
% of Holdings
8.4%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
1,073
Price
$30.58
Total Value
$32.81K
Shares Held After
614,057
% of Holdings
0.2%
Teladoc Health, Inc. (TDOC)
Catapano Joseph Ronald — Chief Accounting Officer
Shares
1,333
Price
$5.12
Total Value
$6.82K
Shares Held After
8,841
% of Holdings
13.1%
American Well Corporation (AMWL)
Zamansky Dmitry — Chief Product & Tech. Officer
Shares
2,472
Price
$5.45
Total Value
$13.47K
Shares Held After
196,242
% of Holdings
1.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
20
Price
$789.28
Total Value
$15.79K
Shares Held After
17,703
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
20
Price
$788.96
Total Value
$15.78K
Shares Held After
17,723
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$787.34
Total Value
$1.57K
Shares Held After
17,743
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
7
Price
$786.61
Total Value
$5.51K
Shares Held After
17,745
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
11
Price
$785.48
Total Value
$8.64K
Shares Held After
17,752
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
9
Price
$784.48
Total Value
$7.06K
Shares Held After
17,763
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
10
Price
$783.62
Total Value
$7.84K
Shares Held After
17,772
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$782.62
Total Value
$1.57K
Shares Held After
17,782
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
5,918
Price
$28.96
Total Value
$171.39K
Shares Held After
164,548
% of Holdings
3.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$781.21
Total Value
$1.56K
Shares Held After
17,784
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
3
Price
$780.69
Total Value
$2.34K
Shares Held After
17,786
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
8,267
Price
$28.96
Total Value
$239.41K
Shares Held After
157,466
% of Holdings
5.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$779.69
Total Value
$3.90K
Shares Held After
17,789
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$778.30
Total Value
$1.56K
Shares Held After
17,794
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
3,870
Price
$28.96
Total Value
$112.08K
Shares Held After
147,733
% of Holdings
2.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
7
Price
$777.46
Total Value
$5.44K
Shares Held After
17,796
% of Holdings
0.0%
Cigna Corporation (CI)
Neville Everett — See Remarks
Shares
1,719
Price
$288.91
Total Value
$496.64K
Shares Held After
5,670
% of Holdings
23.3%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
7,433
Price
$20.30
Total Value
$150.89K
Shares Held After
0
% of Holdings
100.0%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
1,165
Price
$30.58
Total Value
$35.63K
Shares Held After
411,855
% of Holdings
0.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
689
Price
$30.58
Total Value
$21.07K
Shares Held After
212,479
% of Holdings
0.3%
Showing 1401–1450 of 2002 transactions (page 29 of 41)